Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis: prevalence and the role of Cardiopulmonary Exercise Testing and echocardiogram in predicting it
G. Itamaro Heiden (São Paulo, Brazil), J. Barbosa Sobral (São Paulo, Brazil), J. Alves Jr (São Paulo, Brazil), J. Salge (São Paulo, Brazil), A. Albuquerque (São Paulo, Brazil), C. Fernandes (São Paulo, Brazil), R. Kairalla (São Paulo, Brazil), C. Ribeiro Carvalho (São Paulo, Brazil), R. Souza (São Paulo, Brazil), B. Guedes Baldi (São Paulo, Brazil)
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Disease area: Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Itamaro Heiden (São Paulo, Brazil), J. Barbosa Sobral (São Paulo, Brazil), J. Alves Jr (São Paulo, Brazil), J. Salge (São Paulo, Brazil), A. Albuquerque (São Paulo, Brazil), C. Fernandes (São Paulo, Brazil), R. Kairalla (São Paulo, Brazil), C. Ribeiro Carvalho (São Paulo, Brazil), R. Souza (São Paulo, Brazil), B. Guedes Baldi (São Paulo, Brazil). Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis: prevalence and the role of Cardiopulmonary Exercise Testing and echocardiogram in predicting it. 3684
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: